Procurement of Aminophylline Injection and Other Drugs

• Country: Mauritius
• Summary: Procurement of Aminophylline Injection and Other Drugs
• MUT Ref No: 78898908
• Deadline: 02 Mar 2023
• Financier: Self Financed
• Purchaser Ownership: Government
• Tender Value: Refer Document
• Notice Type: Tender
• Document Ref. No.: HEALTH/IFB/2023/1112
• Purchaser's Detail:
  Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.

  Login to see details
• Description:
• Tenders are invited for Procurement of Aminophylline Injection and Other Drugs. IFB - Bid closing 02/03/2023 12:00 PM ITEM NO. DESCRIPTION OF ITEMS QUANTITY REQUIRED PHYSICAL UNIT INCOTERMS/MODE OF TRANSPORT DELIVERY PERIOD AFTER AWARD OF CONTRACT SHELF LIFE REQUESTED RS A1*** Aminophylline Inj. 250 mg/amp IV 1,000 Ampoule CIP/AIR Ex-stock or within 4 weeks as from the date of Letter of Award or at earliest as proposed by bidder 75 to 80% of total shelf life RS A2** Cefuroxime 750 mg Injections 400 Vial CIP/AIR Ex-stock or within 4 weeks as from the date of Letter of Award or at earliest as proposed by bidder 75 to 80% of total shelf life RS A3** Haloperidol Inj. 5 mg/ml x 1 ml 3,000 Ampoule CIP/AIR Ex-stock or within 4 weeks as from the date of Letter of Award or at earliest as proposed by bidder 75 to 80% of total shelf life RS A4*** Vecuronium Bromide Inj. 10 mg vial IV 4,000 Vial CIP/AIR Ex-stock or within 4 weeks as from the date of Letter of Award or at earliest as proposed by bidder 75 to 80% of total shelf life RS A 5** MethylPrednisolone Sodium Succinate Inj. (powder for reconstitution) 40 mg IM/IV 30,000 Vial CIP/AIR Ex-stock or within 4 weeks as from the date of Letter of Award or at earliest as proposed by bidder 75 to 80% of total shelf life RS A6*** Bupivacaine HCL Inj. (Heavy) for Spinal Anaesthesia 0.5% x 4 ml (In individually sterile packs) 4,000 Ampoule CIP/AIR Ex-stock or within 4 weeks as from the date of Letter of Award or at earliest as proposed by bidder 75 to 80% of total shelf life RS A7*** Pralidoxime Methyl Sulphate 200 mg Inj. 300 Vial CIP/AIR Ex-stock or within 4 weeks as from the date of Letter of Award or at earliest as proposed by bidder 75 to 80% of total shelf life RS A8** Metopimazine Injection 10 mg/ml x 1 ml 15,000 Ampoule CIP/AIR Ex-stock or within 4 weeks as from the date of Letter of Award or at earliest as proposed by bidder 75 to 80% of total shelf life RS A9*** Meropenem (as Trihydrate) Inj. IV 1g vial 30,000 Vial CIP/AIR Ex-stock or within 4 weeks as from the date of Letter of Award or at earliest as proposed by bidder 75 to 80% of total shelf life RS A10** Amikacin Sulphate Inj. 50 mg/ml x 1 ml amp IM/IV 1,000 Vial CIP/AIR Ex-stock or within 4 weeks as from the date of Letter of Award or at earliest as proposed by bidder 75 to 80% of total shelf life RS A11** Procyclidine HCL Inj. 5 mg/ml x 2 ml IM/IV 1,500 Ampoule CIP/AIR Ex-stock or within 4 weeks as from the date of Letter of Award or at earliest as proposed by bidder 75 to 80% of total shelf life RS A12** Hyoscine-N Butyl Bromide Injection 20 mg/ml x 1 ml IM/IV 50,000 Ampoule CIP/AIR Ex-stock or within 4 weeks as from the date of Letter of Award or at earliest as proposed by bidder 75 to 80% of total shelf life RS A13*** Meropenem (as Trihydrate) Inj. IV 500 mg vial 20,000 Vial CIP/AIR Ex-stock or within 4 weeks as from the date of Letter of Award or at earliest as proposed by bidder 75 to 80% of total shelf life RS A14** Dexamethasone Phosphate Inj. 8 mg/ampoule IM/IV 50,000 Ampoule CIP/AIR Ex-stock or within 4 weeks as from the date of Letter of Award or at earliest as proposed by bidder 75 to 80% of total shelf life RS A15*** Piperacillin 4 g + Tazobactam 500 mg Inj. IV 8,000 Vial CIP/AIR Ex-stock or within 4 weeks as from the date of Letter of Award or at earliest as proposed by bidder 75 to 80% of total shelf life RS A16*** Methotrexate Inj. 50 mg IV/Intrathecal 300 Vial CIP/AIR Ex-stock or within 4 weeks as from the date of Letter of Award or at earliest as proposed by bidder 75 to 80% of total shelf life RS A17*** Stonefish Antivenom 2000U/Amp Inj 200 Ampoule CIP/AIR Ex-stock or within 4 weeks as from the date of Letter of Award or at earliest as proposed by bidder 75 to 80% of total shelf life
• Documents:

 Tender Notice